Levothyroxine Sodium Tablet
Product Images NDC 51655-483

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-483). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)

Chemical structure diagram of Levothyroxine Sodium showing its atomic arrangement including iodine and sodium ions, with a water of crystallization indicated.*

FDA Label Image

Label (51655 483 26 Master Bottle Label Approval Rev A 11 20)

Label for Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), containing 90 oral tablets. The label indicates prescription use only, storage instructions at 25°C with permitted excursions, and cautions to keep out of reach of children and protect from light and moisture. The product is labeled by Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.